Contact
searchSearch
HMP Global

Commentary

Charles Martin, MD
Commentary
Championing Change in Medical Imaging and Care Delivery with Augmented Imaging
06/26/2024
In this commentary, Charles Martin, MD, discusses the advancing of imaging technologies and how interventional radiologists may be able to use AR to assist in their treatment.
In this commentary, Charles Martin, MD, discusses the advancing of imaging technologies and how interventional radiologists may be able to use AR to assist in their treatment.
In this commentary, Charles...
06/26/2024
Vascular Disease Management
Commentary
What Not To Do in an Office-Based Lab
03/08/2024
Careful selection of which cases not to take is an effective way of avoiding complications in an OBL. Determining what cases to avoid is largely dependent on 4 major variables: the physician, the patient, the procedure, and the OBL itself.
Careful selection of which cases not to take is an effective way of avoiding complications in an OBL. Determining what cases to avoid is largely dependent on 4 major variables: the physician, the patient, the procedure, and the OBL itself.
Careful selection of which cases...
03/08/2024
Vascular Disease Management
OEIS logo
Commentary
OEIS Response to Recent Media Articles Regarding Outpatient Vascular Care
08/02/2023

OEIS Executive Committee

OEIS Executive Committee
One-sided stories do not tell the whole story of the CLI/CLTI epidemic and omit the vast, overwhelming majority of patients who successfully undergo limb salvage/preservation. OEIS believes the better story is one that educates the public...
One-sided stories do not tell the whole story of the CLI/CLTI epidemic and omit the vast, overwhelming majority of patients who successfully undergo limb salvage/preservation. OEIS believes the better story is one that educates the public...
One-sided stories do not tell...
08/02/2023
Vascular Disease Management
Commentary
Platelet Mapping Highlights Our Burgeoning Understanding of Sex Dimorphism in Vascular Disease—and All That We Have Yet to Learn
11/16/2022
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective...
11/16/2022
Vascular Disease Management
Commentary
Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?
10/12/2022
In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.
In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.
In this commentary, the authors...
10/12/2022
Vascular Disease Management
Commentary
Catheterization, Myocardial Infarction, and the COVID-19 Pandemic: The Devil Is in the Details
12/17/2021
Drs. Aijaz and Garcia comment on this issue's Original Research article by Al-Abdouh et al.
Drs. Aijaz and Garcia comment on this issue's Original Research article by Al-Abdouh et al.
Drs. Aijaz and Garcia comment on...
12/17/2021
Vascular Disease Management
Editorial/Commentary
Proper Shielding Technique in Protecting Against Scatter Radiation
06/11/2021
Radiation shielding can provide effective protection from scatter radiation during vascular angiographic procedures.
Radiation shielding can provide effective protection from scatter radiation during vascular angiographic procedures.
Radiation shielding can provide...
06/11/2021
Vascular Disease Management
Commentary
The First Well-Documented Report of Carotid Endarterectomy in a Patient With COVID-19 Related Stroke
05/11/2020
The COVID-19 pandemic has caused sudden and severe illness with high mortality and threatens to overwhelm healthcare systems.
The COVID-19 pandemic has caused sudden and severe illness with high mortality and threatens to overwhelm healthcare systems.
The COVID-19 pandemic has caused...
05/11/2020
Vascular Disease Management
Commentary Regarding Katsanos et al's Meta-Analysis: The Lessons Learned Should Impose Prudence and Caution
Commentary
Commentary Regarding Katsanos et al's Meta-Analysis: The Lessons Learned Should Impose Prudence and Caution
01/14/2020
Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.
Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.
Francesco Liistro, MD, comments...
01/14/2020
Vascular Disease Management
Commentary
Technology Must Meet Efficacy in Treating ALI
11/04/2019
Paul Michael, MD, comments on a single-center, observational experience of patients treated for acute limb ischemia by Estes and colleagues, and congratulates the group for wanting to constantly improve their state of thrombolysis therapy.
Paul Michael, MD, comments on a single-center, observational experience of patients treated for acute limb ischemia by Estes and colleagues, and congratulates the group for wanting to constantly improve their state of thrombolysis therapy.
Paul Michael, MD, comments on a...
11/04/2019
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Hypertension
Medtronic Announces CMS National Coverage Analysis for Symplicity™ Spyral Renal Denervation System
01/14/2025
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
The Symplicity Spyral RDN...
01/14/2025
Cath Lab Digest
Pulmonary Embolism
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
01/13/2025
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F1885 System in pulmonary embolism treatment. LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 13,...
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F1885 System in pulmonary embolism treatment. LATHAM, N.Y.--(BUSINESS WIRE)--Jan. 13,...
Peer-reviewed data highlights...
01/13/2025
Vascular Disease Management
Thrombectomy
Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients With Pulmonary Embolism
01/13/2025
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational...
MENLO PARK, Calif., Jan. 13,...
01/13/2025
Vascular Disease Management
Bioresorbable Scaffolds
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDE Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
01/13/2025
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead...
01/13/2025
Vascular Disease Management
News
20th Anniversary Leipzig Interventional Course (LINC) to Feature 40+ Live Cases, First-to-podium Data Releases
01/13/2025
Clinicians from Germany, Dubai, Japan, U.S., Switzerland among scrub-in and live case transmissions; educational program features 500+ vascular, endovascular presentations. MALVERN PA., (January 13, 2024) — First-to-podium data...
Clinicians from Germany, Dubai, Japan, U.S., Switzerland among scrub-in and live case transmissions; educational program features 500+ vascular, endovascular presentations. MALVERN PA., (January 13, 2024) — First-to-podium data...
Clinicians from Germany,...
01/13/2025
Vascular Disease Management
Ischemic Stroke
Medtronic Expands U.S. Carotid Market Presence With Exclusive Contego Medical Distribution Agreement
01/13/2025
This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, post-dilation...
This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, post-dilation...
This agreement includes Contego...
01/13/2025
Cath Lab Digest
Clot-Sensing Guidewire
Sensome Announces Data From Two New Studies Showing Clot-Sensing Guidewire Successfully Identifies Fresh Clot to Support Decision-Making in Peripheral Artery Disease Treatment
12/13/2024
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two...
12/13/2024
Vascular Disease Management
News
Echo IQ Signs Integration Agreement With Flagship US Hospital
12/12/2024
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the...
12/12/2024
Vascular Disease Management
Terumo R2P Navicross
Radial to Peripheral
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
12/03/2024
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P...
12/03/2024
Cath Lab Digest
Bridging Stent for FEVAR
World premiere for Bentley’s BeFlared Bridging Stent: Successful “First in Man” Operation
12/02/2024
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024...
12/02/2024
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use